Skip Navigation

This Article
Right arrow Print PDF (5270K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Deshmane Sista, N.
Right arrow Articles by Pagano, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deshmane Sista, N.
Right arrow Articles by Pagano, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1995, Vol. 23, No. 10 1729-1736
© 1995


MOLECULAR BIOLOGY

Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR{alpha} and RXR{alpha}

Nirupama Deshmane Sista1,3,*, Christopher Barry1, Kimberly Sampson1 and Joseph Pagano1,2,3

1109 UNC-Lineberger Comprehensive Cancer Center USA 2Department of Medicine USA 3Department of Microbiology, University of North Carolina at Chapel Hill Chapel Hill, NC 27599-7295, USA

* To whom correspondence should be addressed

Received February 6, 1995. Accepted February 23, 1995.

Epstein-Barr virus (EBV) reactivation, indicated by induction of EBV early antigens from latently Infected lymphoid cell lines by phorbol esters, Is inhibited by retinoic acid (RA). Viral reactivation, which Is triggered by the immediate-early BZLF-1 (Z) viral gene product, is repressed by retinoic acid receptors (RARs) RAR{alpha} and RXR{alpha}. These proteins negatively regulate Z-mediated transactlvation of the promoter for an EBV early gene product, early antigen-diffuse (EaD). Here we confirm a direct physical interaction between the AP1-llke protein Z and RXR{alpha} and map the domains of Interaction In the Z protein and RXR{alpha}. The domain required for homodimerlzation of Z is separate from that required for its interaction with RXR{alpha}. Z also has the effect of repressing activation of an RAR-respon-slve cellular promoter (BRE). Point mutants In the dimerlzation domain of Z unable to interact with RXR{alpha} do not repress RXR{alpha}-medlated transactivation of BRE, the promoter for RARß, which suggests that Interaction between the two proteins is required for this repressor effect. The domain of RXR{alpha} required for interaction with Z has been mapped, and is again separate from that required for homodimerization. These results indicate that a ‘cross-coupling’ or direct interaction between Z and RAR{alpha} and RXR{alpha} can modulate the reactivation of latent EBV infection and suggest that, reciprocally, the viral protein Z may influence cellular regulatory pathways.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
R.-C. Jiang, H.-D. Qin, M.-S. Zeng, W. Huang, B.-J. Feng, F. Zhang, H.-K. Chen, W.-H. Jia, L.-Z. Chen, Q.-S. Feng, et al.
A Functional Variant in the Transcriptional Regulatory Region of Gene LOC344967 Cosegregates with Disease Phenotype in Familial Nasopharyngeal Carcinoma
Cancer Res., January 15, 2006; 66(2): 693 - 700.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Izumiya, T. J. Ellison, E. T. H. Yeh, J. U. Jung, P. A. Luciw, and H.-J. Kung
Kaposi's Sarcoma-Associated Herpesvirus K-bZIP Represses Gene Transcription via SUMO Modification
J. Virol., August 1, 2005; 79(15): 9912 - 9925.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. S. El-Guindy and G. Miller
Phosphorylation of Epstein-Barr Virus ZEBRA Protein at Its Casein Kinase 2 Sites Mediates Its Ability To Repress Activation of a Viral Lytic Cycle Late Gene by Rta
J. Virol., July 15, 2004; 78(14): 7634 - 7644.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. J. Sinclair
bZIP proteins of human gammaherpesviruses
J. Gen. Virol., August 1, 2003; 84(8): 1941 - 1949.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. H. Dreyfus, M. Nagasawa, C. A. Kelleher, and E. W. Gelfand
Stable expression of Epstein-Barr virus BZLF-1-encoded ZEBRA protein activates p53-dependent transcription in human Jurkat T-lymphoblastoid cells
Blood, July 15, 2000; 96(2): 625 - 634.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
S. Aho, M. Buisson, T. Pajunen, Y. W. Ryoo, J.-F. Giot, H. Gruffat, A. Sergeant, and J. Uitto
Ubinuclein, a Novel Nuclear Protein Interacting with Cellular and Viral Transcription Factors
J. Cell Biol., March 20, 2000; 148(6): 1165 - 1176.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. H. Dreyfus, M. Nagasawa, J. C. Pratt, C. A. Kelleher, and E. W. Gelfand
Inactivation of NF-{kappa}B by EBV BZLF-1-Encoded ZEBRA Protein in Human T Cells
J. Immunol., December 1, 1999; 163(11): 6261 - 6268.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z. Gao, A. Krithivas, J. E. Finan, O. J. Semmes, S. Zhou, Y. Wang, and S. D. Hayward
The Epstein-Barr Virus Lytic Transactivator Zta Interacts with the Helicase-Primase Replication Proteins
J. Virol., November 1, 1998; 72(11): 8559 - 8567.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Baumann, H. Mischak, S. Dammeier, W. Kolch, O. Gires, D. Pich, R. Zeidler, H.-J. Delecluse, and W. Hammerschmidt
Activation of the Epstein-Barr Virus Transcription Factor BZLF1 by 12-O-Tetradecanoylphorbol-13-Acetate-Induced Phosphorylation
J. Virol., October 1, 1998; 72(10): 8105 - 8114.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Larose, A.-M. Cassard-Doulcier, C. Fleury, F. Serra, O. Champigny, F. Bouillaud, and D. Ricquier
Essential cis-Acting Elements in Rat Uncoupling Protein Gene Are in an Enhancer Containing a Complex Retinoic Acid Response Domain
J. Biol. Chem., December 6, 1996; 271(49): 31533 - 31542.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.